Institute for Cardiovascular Prevention, Ludwig-Maximilians-University of Munich Munich, Germany.
Front Immunol. 2012 Jul 12;3:175. doi: 10.3389/fimmu.2012.00175. eCollection 2012.
Chemoattractant cytokines or chemokines constitute a family of structurally related proteins found in vertebrates, bacteria, or viruses. So far, 48 chemokine genes have been identified in humans, which bind to around 20 chemokine receptors. These receptors belong to the seven transmembrane G-protein-coupled receptor family. Chemokines and their receptors were originally studied for their role in cellular trafficking of leukocytes during inflammation and immune surveillance. It is now known that they exert different functions under physiological conditions such as homeostasis, development, tissue repair, and angiogenesis but also under pathological disorders including tumorigenesis, cancer metastasis, inflammatory, and autoimmune diseases. Physicochemical properties of chemokines and chemokine receptors confer the ability to homo- and hetero-oligomerize. Many efforts are currently performed in establishing new therapeutically compounds able to target the chemokine/chemokine receptor system. In this review, we are interested in the role of chemokines in inflammatory disease and leukocyte trafficking with a focus on vascular inflammatory diseases, the operating synergism, and the emerging therapeutic approaches of chemokines.
趋化因子细胞因子或趋化因子构成了一个在脊椎动物、细菌或病毒中发现的结构相关蛋白家族。到目前为止,人类已经鉴定出 48 种趋化因子基因,它们与大约 20 种趋化因子受体结合。这些受体属于七次跨膜 G 蛋白偶联受体家族。趋化因子及其受体最初是因其在炎症和免疫监视期间白细胞的细胞运输中的作用而被研究的。现在已知,它们在生理条件下(如稳态、发育、组织修复和血管生成)以及在病理紊乱(包括肿瘤发生、癌症转移、炎症和自身免疫性疾病)下发挥不同的功能。趋化因子和趋化因子受体的物理化学特性赋予了它们同型和异型寡聚化的能力。目前,人们正在努力建立能够靶向趋化因子/趋化因子受体系统的新治疗化合物。在这篇综述中,我们关注趋化因子在炎症性疾病和白细胞运输中的作用,重点关注血管炎症性疾病、协同作用以及趋化因子的新兴治疗方法。